Healthcare AI RevOps

Three impossible interwoven strips surround an open center — *Intelligence in the in-between*Intelligence & orchestration

Healthcare RevOps support that makes CRM, lifecycle data, attribution, AI-assisted prioritization, and revenue-quality reporting operational.

Read the operating brief

Proposed mandate workflow

From lifecycle truth to revenue-quality decisions

Define real handoffs
Ground HubSpot stages in healthcare operating work and accountable transitions.
Establish source truth
Connect referral tags, attribution, cohorts, CAC, and LTV definitions.
Prioritize within capacity
Use AI-assisted lead or account scoring where it improves commercial decisions.
Run the leadership cadence
Review revenue-quality dashboards to direct budgets, capacity, and next actions.

Proposed service workflow: lifecycle definitions and shared source truth precede automation and executive reporting.

The buyer problem

The issue underneath the visible activity.

This is the problem leadership must make legible before adding more pipeline, tooling, headcount, or implementation burden.

CRM exists, but the company still lacks lifecycle clarity, source truth, attribution discipline, capacity-aware prioritization, and executive operating cadence.

What gets built

A working management system, not a recommendation left in a deck.

The scope is organized around the artifacts, operating rules, and decision cadence the team needs to keep using after the engagement.

01
HubSpot lifecycle architecture grounded in healthcare operating stages.
02
Source, attribution, cohort, CAC, LTV, and referral tagging discipline.
03
AI-assisted lead or account prioritization where it improves commercial decision-making.
04
Revenue-quality dashboards for leadership cadence, not vanity reporting.

Proof patterns

What leadership should be able to observe.

01
Clinician supply expansion through lifecycle architecture.
02
Acquisition quality and qualified pipeline improved through RevOps discipline.
03
Patient value logic improved through cohort and lifecycle discipline.

Decision questions

What the executive room must answer.

01
Which lifecycle stages are real operating handoffs?
02
Where should AI assist prioritization without making clinical decisions?
03
What source or cohort data would change budget decisions?

Trust boundary

What this mandate will not pretend away.

Do not use AI as decoration if it does not change prioritization.
Do not automate broken lifecycle definitions.
Do not let marketing, sales, and operations report from different truths.

Related proof

These records are contextual proof paths, not blanket client-outcome claims. Evidence class and claim boundary are shown from the public case record where available.

Employer outcome

Behavioral Health Growth / AI RevOps

Access demand -> lifecycle intelligence

Claim boundary

Only aggregate operating outcomes are shown. Provider-level, patient-level, payer-contract, and internal claims files remain private.

Employer outcome

Databricks Claims Forensics / Referral Leakage

Claims signal -> account strategy

Claim boundary

Aggregate results are reported in the September 12, 2026 executive resume. The $125.9M leakage figure is a modeled opportunity and $22M downstream LTV is an estimate, not realized or booked revenue. Account-level and patient-level records remain private.

Connected context

Start a serious conversation

Make the buyer problem clear enough to build, prove, and fund.

Discuss an operating mandate